| Product Code: ETC8886125 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Portugal continues to rely heavily on neighboring countries for hemostatic agents, with Spain, Italy, and Germany leading the way in 2024. The market shows high concentration, indicating limited diversification in import sources. Despite a modest compound annual growth rate of 1.21% from 2020 to 2024, there was a notable uptick in growth from 2023 to 2024 at 7.1%. This suggests a potential acceleration in demand or shifts in market dynamics driving increased imports of hemostatic agents into Portugal.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Portugal Hemostatic Agents Market Overview |
3.1 Portugal Country Macro Economic Indicators |
3.2 Portugal Hemostatic Agents Market Revenues & Volume, 2021 & 2031F |
3.3 Portugal Hemostatic Agents Market - Industry Life Cycle |
3.4 Portugal Hemostatic Agents Market - Porter's Five Forces |
3.5 Portugal Hemostatic Agents Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Portugal Hemostatic Agents Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Portugal Hemostatic Agents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing number of surgeries and trauma cases in Portugal |
4.2.2 Growing awareness about the importance of hemostatic agents in medical procedures |
4.2.3 Technological advancements in hemostatic agents leading to improved efficacy and safety |
4.3 Market Restraints |
4.3.1 High cost associated with advanced hemostatic agents |
4.3.2 Stringent regulatory requirements for approval of hemostatic products in Portugal |
5 Portugal Hemostatic Agents Market Trends |
6 Portugal Hemostatic Agents Market, By Types |
6.1 Portugal Hemostatic Agents Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Portugal Hemostatic Agents Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Portugal Hemostatic Agents Market Revenues & Volume, By Active Agents, 2021- 2031F |
6.1.4 Portugal Hemostatic Agents Market Revenues & Volume, By Passive Agents, 2021- 2031F |
6.1.5 Portugal Hemostatic Agents Market Revenues & Volume, By Combination, 2021- 2031F |
6.2 Portugal Hemostatic Agents Market, By Distribution Channel |
6.2.1 Overview and Analysis |
6.2.2 Portugal Hemostatic Agents Market Revenues & Volume, By Large Hospital (500+ Beds), 2021- 2031F |
6.2.3 Portugal Hemostatic Agents Market Revenues & Volume, By Medium Hospital (250-499 Beds), 2021- 2031F |
6.2.4 Portugal Hemostatic Agents Market Revenues & Volume, By Small Hospitals (Less than 250 Beds), 2021- 2031F |
7 Portugal Hemostatic Agents Market Import-Export Trade Statistics |
7.1 Portugal Hemostatic Agents Market Export to Major Countries |
7.2 Portugal Hemostatic Agents Market Imports from Major Countries |
8 Portugal Hemostatic Agents Market Key Performance Indicators |
8.1 Adoption rate of advanced hemostatic agents in Portuguese hospitals |
8.2 Number of research studies and clinical trials conducted on hemostatic agents in Portugal |
8.3 Rate of complications or adverse events reported with the use of hemostatic agents in medical procedures |
9 Portugal Hemostatic Agents Market - Opportunity Assessment |
9.1 Portugal Hemostatic Agents Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Portugal Hemostatic Agents Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Portugal Hemostatic Agents Market - Competitive Landscape |
10.1 Portugal Hemostatic Agents Market Revenue Share, By Companies, 2024 |
10.2 Portugal Hemostatic Agents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |